Results 271 to 280 of about 1,144,970 (369)

Determinants of alpha-synuclein pathogenesis in Parkinson's disease. [PDF]

open access: yesNeural Regen Res
Bárcenas O   +2 more
europepmc   +1 more source

Non-denaturing purification of alpha-Synuclein from erythrocytes [PDF]

open access: hybrid, 2011
Tim Bartels   +4 more
openalex   +1 more source

RAB32‐Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria

open access: yesMovement Disorders, EarlyView.
Abstract Background The RAB32 p.Ser71Arg variant is a novel cause of monogenic Parkinson's disease (PD), for which detailed phenotypic information is currently scarce. Objectives Our aim was to clinically and biologically characterize individuals with PARK‐RAB32 to gain insights into genotype–phenotype relationships, disease severity, and underlying ...
Teresa Kleinz   +27 more
wiley   +1 more source

Alpha-Synuclein as a Potential Biomarker for Inclusion Body Myositis in Blood and Muscle. [PDF]

open access: yesNeuropathol Appl Neurobiol
Mayer T   +14 more
europepmc   +1 more source

Beyond Pathology: α‐Synuclein Homeostasis and Three Principles to Guide Research

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Alberto J. Espay, Andrew J. Lees
wiley   +1 more source

Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence

open access: yesMovement Disorders, EarlyView.
Abstract Background The vagus nerve (VN), the principal component of the parasympathetic branch of the autonomic nervous system (ANS), mediates bidirec communication between the central nervous system (CNS) and peripheral organs. Vagus nerve stimulation (VNS), delivered through invasive (iVNS) or non‐invasive (transcutaneous cervical [tcVNS] and ...
Francesca Proietti   +9 more
wiley   +1 more source

Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1. [PDF]

open access: yesCell Rep
Cabaj M   +23 more
europepmc   +1 more source

Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial

open access: yesMovement Disorders, EarlyView.
Abstract Background Gut dysbiosis and gut‐brain‐axis involvement in people with Parkinson's disease (PwP) support the use of gut‐microbiota‐modulating interventions. Probiotics may help manage constipation in PwP; however, mechanisms underpinning additional beneficial properties are unknown.
Valentina Leta   +30 more
wiley   +1 more source

Home - About - Disclaimer - Privacy